Sign in
VCYT Stock Price, Chart, Stats & News
Veracyte, Inc.
Save
Veracyte, Inc. (VCYT) does not currently pay a dividend.
4.75B
Market cap
29.76x
Current P/E
33.44x
Forward P/E
VCYT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 70.63% |
Operating margin | 9.00% |
Pretax margin | 13.19% |
Net margin | 12.83% |
Effective tax rate | 2.71% |
ROA | 4.72% |
ROE | 5.33% |
D/E | 0.03x |
Interest coverage ratio | – |
VCYT valuation
P/E | 29.76x |
P/S | 4.61x |
P/B | 1.81x |
P/CF | 17.43x |
P/FCF | 18.91x |
P/OCF | 17.43x |
PEG | 0.31x |
EV multiple | 32.48x |
About
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services.
Similar securities
Based on sector and market capitalization
Report issue